Company intelligence / Profile preview

SkinVision

Amsterdam, North Holland, Netherlands

Ownership: Private
Employees: ~64
Development stage: Commercial

Overview

SkinVision’s mobile app uses clinically validated AI algorithms and dermatologist oversight to assess the risk of skin lesions for skin cancer. The app has demonstrated high sensitivity and specificity in clinical studies—up to 95% sensitivity and 78% specificity for detection of various types of skin cancer. It is CE-marked as a regulated medical device in Europe and has been used by over 3 million users worldwide with more than 5 million checks performed. The company continues to expand its dataset and improve accuracy through machine learning.

Therapeutic areas: OncologyDermatology
Modalities: DeviceArtificial intelligence (AI)Mobile application
Industry: Digital Health Medical Devices

Partnerships

Not explicitly listed in search results; the company aims to build ties with national healthcare systems and insurers. No major pharma/biotech partnerships disclosed.

Beyond the preview

Go deeper on SkinVision.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SkinVision.

Explore the full profile